Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00237185
Status:
COMPLETED
Last Update Posted:
2014-08-19
First Post:
2005-10-09
Brief Title:
A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis